Nearly a third of all private equity-owned health care businesses in Europe have been held for at least five years, according to the new HBI Deals Pipeline tool. That suggests many private equity houses are struggling to sell on their investments.
C-sections now account for a third of all maternity costs under Kenya's national health insurance scheme, with some experts concerned that operators have been cashing in on inflated prices.
The Dubai Health Authority (DHA) has shut down a private hospital for three months, citing regulatory non-compliance without naming the facility. HBI sources indicate which one it might be.
South Africa's national health insurance (NHI) reform could seriously disrupt the country's lab and radiology markets, a well-placed advisor tells HBI. But the country's Big Three hospital groups and Big Three lab chains are unlikely to reap the benefits, potentially opening up the market to smaller players.
Pan-Asian hospital group IHH Healthcare is reportedly mulling the sale of its Indian hospital assets Global and Continental Hospitals, although the listed group has said no definitive decision has been made and tells HBI it is "committed to growing in India."
Evercare, part of what was formerly the Abraaj Growth Markets Health Fund (AGHF) and now managed by global PE firm TPG, has appointed a new CEO to oversee its hospitals and clinics in India, Pakistan, Kenya and Nigeria.
Conglomerate-owned Italian hospital group Humanitas is in the process to buy Romanian healthcare group Regina Maria. HBI understands Mid Europa tried to sell the company before summer without success, possibly because of the price.
An outsider who doesn’t believe in “old answers” and wants to ‘’do things differently’’, Soi, 46, has big plans for the about-to-be-merged Max and Radiant businesses. The large Indian hospital chain is backed by private equity firm KKR-with 12 large and metro-based hospitals and 4 day-care centres, with 2019-20 expected sales of INR 4,200 crores (US$631m), making it second only to Apollo He talks exclusively to HBI about his plans and where he sees growth.
BR Salud, the Spanish JV owned by Unilabs and Ribera Salud, has lost its multi-million euro public contract to the country's fourth-largest lab group Analiza. It was worth, HBI estimates, 15-20% of Unilabs' Spain revenue.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.